Cargando…
Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations
Malaria is an infectious disease which disproportionately effects children and pregnant women. These vulnerable populations are often excluded from clinical trials resulting in one‐size‐fits‐all treatment regimens based on those established for a nonpregnant adult population. Pharmacokinetic/pharmac...
Autores principales: | Hughes, Emma, Wallender, Erika, Mohamed Ali, Ali, Jagannathan, Prasanna, Savic, Radojka M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518425/ https://www.ncbi.nlm.nih.gov/pubmed/33763871 http://dx.doi.org/10.1002/cpt.2238 |
Ejemplares similares
-
Interplay among malnutrition, chemoprevention, and the risk of malaria in young Ugandan children: Longitudinal pharmacodynamic and growth analysis
por: Ali, Ali Mohamed, et al.
Publicado: (2023) -
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children
por: Wallender, Erika, et al.
Publicado: (2021) -
Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK/PD pharmacometrics of rezafungin efficacy
por: Miesel, Lynn, et al.
Publicado: (2019) -
Response to “Quantitative Clinical Pharmacology INPUT to SARS‐CoV‐2 Therapeutics Should be Based on Robust Data”
por: Garcia‐Cremades, Maria, et al.
Publicado: (2020) -
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria
por: Saralamba, Sompob, et al.
Publicado: (2023)